Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
Astoria gives patients in western Queens a Spravato option that is easier to reach than traveling into Midtown or out to Long Island.
View Spravato details for AstoriaSpravato vs ketamine
If you are comparing ketamine therapy, esketamine, and Spravato in Jackson Heights, start with the treatment pathway Nao Medical actively supports: FDA-approved Spravato care for eligible adults, delivered in a certified setting with monitoring and insurance coordination.
Many patients looking for ketamine therapy when they are really trying to understand advanced depression treatment options. Spravato is related to ketamine, but it is not the same as IV ketamine infusion. Spravato is esketamine nasal spray and is administered through a structured REMS process in a certified medical setting.
Nao Medical uses these care options to route patients away from vague ketamine claims and toward the active Spravato program, where eligibility, safety, insurance, scheduling, and transportation planning can be handled clearly.
Patients in Jackson Heights can review nearby Nao Medical Spravato options below or start with the main Spravato treatment details for eligibility, insurance, and booking details.
Queens
37-15 23rd Ave, Astoria, NY 11105
Astoria gives patients in western Queens a Spravato option that is easier to reach than traveling into Midtown or out to Long Island.
View Spravato details for AstoriaQueens
30-07 36th Ave, Astoria, NY 11106
Long Island City is a strong option for patients in western Queens and nearby Manhattan who want a realistic route back for repeated monitored visits.
View Spravato details for Long Island CityQueens
90-18 Sutphin Blvd, Jamaica, NY 11435
Jamaica is an important access point for southeast Queens patients who need a consistent, supervised Spravato schedule.
View Spravato details for JamaicaPatients comparing ketamine-related care can review local Spravato and related treatment options here. Nao Medical's active advanced depression pathway is Spravato, which is esketamine nasal spray administered in a certified healthcare setting.
No. Spravato is esketamine nasal spray and has FDA-approved uses for eligible adults. Ketamine infusion is different and is commonly discussed as an off-label treatment.
No. Spravato is administered only in a certified healthcare setting, and patients are monitored after dosing.
Many plans cover Spravato for eligible patients, but benefits, diagnosis, and prior authorization requirements vary. Nao Medical can help with verification before treatment starts.